Curesponse Israeli Company
Curesponse’s technology represents the next step in personalized cancer medicine, advancing prediction capabilities beyond genomics to understand how cancer treatments will affect the patient’s tumor cells when they are in their native tumor.
Health Tech & Life Sciences
Biotechnology
Health Care
Medical
Medical Device
Alternatives
No alternatives listed yet.
Suggest an Alternative
Founders
Parent Companies/Investors
Office Locations
London, United Kingdom
Rehovot, Israel
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/curesponse
[2]
crunchbase.com
- https://www.crunchbase.com/organization/curesponse
External links are provided for reference and verification purposes.